TrialBone marrow transplantation2015

Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation.

A Israyelyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.